Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06275659 · ClinicalTrials.gov registry record · NA
An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis
A NA study, sponsored by Click Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT06275659 is a NA study that has completed, run by Click Therapeutics. The registered enrollment target is 120 participants.
The verdict
NCT06275659, a NA study, has completed, sponsored by Click Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-based prescription digital therapeutics. One class of CT-100 components are Digital Neuro-activation and Modulation (DiNaMo TM) components. DiNaMo components target key neural systems (including but not limited to systems related to sensory-, perceptual-, affective-, pain-, attention-, cognitive control, social- and self- processing) to optimally improve a participant's health.
Interventions
- DEVICE CT-100-004-A
- DEVICE CT-100-004-B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2024-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06275659
The ClinicalTrials.gov registry entry for NCT06275659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Click Therapeutics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CT-100-004-A is the first listed.
NCT06275659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06275659 about?
NCT06275659 is a clinical study titled "An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis". CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a treatment in future software-based prescription digital therapeutics. One class of CT-100 components are Digital Neuro-activation and Modulation (DiNaMo TM) components. DiNaMo compone...
What is the current status of trial NCT06275659?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2023-12-04. Estimated completion is 2024-02-23.
What interventions are being tested in trial NCT06275659?
The interventions under investigation include: CT-100-004-A (DEVICE), CT-100-004-B (DEVICE).
Who is sponsoring clinical trial NCT06275659?
This trial is sponsored by Click Therapeutics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.